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Pharmacy Research at URI: Mining Red Maple
(Acer rubrum) Trees for Novei Therapeutics
to Manage Diabetes
Navindra P. Seeram, PhD, Jialin Xu, PhD, Liya Li, PhD, and Angela Slitt, PhD
Study ofmaple for novel therapeu- intervals afi:er the sucrose challenge. Comtics. The sugar maple {Acer saccharum) pared to acarbose, MBE was less effective,
and red maple plant species are native but did impart a significant inhibitory
to eastern North America and highly effect. We now hope to further purify
regarded for their sap which is used to pro- and evaluate individual phytochemicals
duce the natural sweetener, maple syrup. of MBF to evaluate for activity against
Our laboratory has recently identified a sucrose-induced glucose elevation.
number of phenolic compounds native
We have demonstrated that phenolic
in maple plant parts that are also present glycosides are present in various maple
in maple syrup.^
constituents. The isolated compounds
Here we report a case study in which and extracts inhibit a-glucosidase activity
the ability of red maple bark extract in vitroJ-* Recently, multiple gallotannins,
(MBE) to decrease elevation of blood named maplexins A-E, were isolated
glucose levels was investigated. Male from red maple stems and bark.^'* These
adult C57BL/6 mice were administered maplexin compounds were shown in vitro
MBF in combination with a bolus sucrose to possess more activity than acarbose for
challenge to evaluate the effect of MBE inhibition of a-glucosidase activity (IC^^^
or acarbose on a-glucosidase activity in = 8 vs. 160 pM; maplexin E vs. acarbose,
vivo according to described methods.^' As respectively). These interesting maplexin
expected, mice receiving a bolus sucrose compounds, that are as effective as acchallenge increased blood glucose con- arbose in vitro, will be further evaluated
centration 30, 60, and 90 minutes after and developed to determine whether they
Plantpolyphenols as a-glucosidase administration compared to initial blood impart beneficial properties in preventing
inhibitors. Dietary carbohydrates are glucose concentration. (Figure 1) Both blood glucose elevations in vivo. Overall,
hydrolyzed by pancreatic a-amylase MBE and acarbose significantly lowered we determined that MBE contains bioacwith absorption aided by a-glucosidases blood glucose concentrations at these time tive constituents that can potentially aid
and thus, inhibition of the activities of
these enzymes is a promising approach
for managing T2DM. In fact, the clinilSO.OO
cal a-glucosidase inhibitor, acarbose,
has been shown to effectively reduce
c
170.00
O
glycated hemoglobin levels when given as
acarbo5c
150.00
monotherapy or as an add-on to other antidiabetic drug treatment.' Additionally,
c
(LI
130.00
U
afixeddose combination of acarbose and
metformin was reported to be superior to
u 5, 110.00
metformin alone in controlling HbAlc,
01 œ
8
1 90.00
fasting blood glucose, and post prandial
u
blood glucose levels in T2DM patients,^ as
well as, enhancing the blood glucose con70.00
trol.' Multiple plant-derived polyphenols
50.00
have been investigated as a-glucosidase
20
40
60
SO
100
120
140
inhibitors. Extracts from grape seeds and
green tea been demonstrated to exert
Minutes After Sucrose Administration
inhibition on a-glucosidase activity.'* We
Figure 1. Adult male C57BL/6 mice were administered sucrose (3g/kg BW), sucrose
recently have shown a similar activity
and acarbose (3g/kg BW + 3 mg/kg BW), or 3) sucrose and maple bark extract (3g/kg
for phenolic-enriched extracts from the
bark oí Acer rubrum, commonly known BW+150mg/kg BW) by oral gavage. Blood glucose levels were determined by tail bleed at 0,
30, 60, 90, and 120 minutes post sucrose administration. An asterisk (*) denotes statistical
as red maple.
TYPE 2 DIABETES MELLITUS (T2DIVI)

artî

accounts for about 90% of all diagnosed
cases of diabetes in adults. Over 200 million people suffer from this disease worldwide. In the United States alone, in 2007,
10% of American adults had diabetes and
the cost of management was $174 billion
and this figure is expected to skyrocket
(Centers for Disease Control and Prevention, 2010). Plants and their derived
products have been used for centuries by
various cultures as traditional medicines
for the management of diabetes. Plants
contain secondary metabolites (known
as phytochemicals; 'phyto' means plant),
which are implicated in the prevention
and treatment of several chronic human
diseases, including diabetes. Among
these natural products, polyphenols and
phenolic glycosides, have attracted significant interests for their anti-diabetic
properties.

significance (p<0.05) from the sucrose treatment group.
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in the regulation of blood glucose control
after a carbohydrate challenge.
We will continue to explore how
bioactive extracts and molecules isolated
from plants can impart beneficial effects
on metabolic syndrome. As metabolic
syndrome encompasses T2DM, dyslipidemia, systemic inflammation, and nonalcoholic fatty liver disease, the potential
therapeutics isolated will be tested in
various cell-based and in vivo models. We
are currently exploring anti-inflammatory
effects of maple-derived extracts and
compounds, as well as, the potential for
plant-derived extracts to augment weight
loss andT2DM therapies. Ultimately, we
hope that identification of beneficial components in foods commonly consumed
can arm the consumer with information
to make better food choices that can be
synergistic with drug therapies used to
treat T2DM. We also will continue to
mine botanicals for potential therapies
to treat T2DM or enhance activity of
commonly prescribed anti-diabetes
therapies.
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